Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for prevention of postoperative delirium after laparoscopic colorectal cancer surgery in older adults
ChiCTR2500101702Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in postoperative delirium (POD) and colorectal cancer (CRC) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Incidence of postoperative delirium. Started Jun 2023; status: recruiting.
02
Drugs
remimazolampropofol
03
Conditions
postoperative delirium (POD)colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2500101702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101702.